I'm noticing Novo Nordisk pop back on everyone’s radar with all this GLP‑1 craze. I guess slimming dr-gs are hot money right now. That Alzheimer study buzz is hot too, it could open a whole new market if true. I think this is a good investment at this point, because I can't find a true downside.
There are no replies in this thread yet. Be the first to post a reply below: